In SilicoDrug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis

Author:

Knoll Kirsten E.1ORCID,van der Walt Mietha M.1ORCID,Loots Du Toit1

Affiliation:

1. Human Metabolomics, North-West University, Potchefstroom, South Africa

Abstract

This article elaborates on the mechanism of action of a novel antibiotic compound against both, active and dormantMycobacterium tuberculosisand describes its pharmacokinetics (including oral bioavailability and toxicity). Information provided in this article serves useful during the search for drugs that shorten the treatment regimen for Tuberculosis and cause minimal adverse effects.

Funder

North-West University

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference99 articles.

1. WHO. 2020. Global tuberculosis report 2020. World Health Organization Geneva. https://creativecommons.org/licenses/by-nc-sa/3.0/igo.

2. WHO. 2019. Consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization.

3. Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis

4. Bacterial cell wall quality control during environmental stress;Mueller EA;Mol Biol Physiol,2020

5. Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3